The effect of high-altitude exposure on Vogt-Koyanagi-Harada syndrome: a case report Authors: Qihang Lei, Xiangli Wang, Qin Liu Published: 2025 ABSTRACT AbstractBackgroundVogt-Koyanagi-Harada (VKH) is a rare and complex autoimmune disease that primarily affects the eyes and the central nervous system. The underlying mechanism of this disease remains unclear, but it is closely related to genetic susceptibility, environmental factors, and abnormal immune responses. This report presents a case of VKH syndrome potentially associated with High-altitude exposure, It highlights that environmental factors may act as a catalyst for the onset of this disease. High altitude can cause retinal lesions from UV radiation and hypoxia, risking visual health. Limited data on VKH in these contexts emphasizes the need for caution among VKH patients traveling to high altitudes.Case presentationA 31-year-old female experienced sudden blurred vision, eye swelling, pain, redness, headache, and tinnitus after a trip to Lhasa, Tibet, where she stayed at high altitude. She had no significant medical history and left the area after symptoms began. Examination showed low visual acuity, normal intraocular pressure, conjunctival injection, and retinal detachment. After diagnosis, she received high-dose steroid therapy, leading to significant improvement in her vision.ConclusionHigh-altitude illness (HAI) arises from hypoxia above 2,500 m, causing symptoms like headaches and fatigue, and significantly impacts VKH syndrome through factors like UV radiation and tissue hypoxia. It may alter immune balance, posing risks for VKH patients in high-altitude areas. In the summary and reflection of this case, we recognized the complexity of VKH and its relationship with environmental factors. Altitude sickness may pose a serious threat to patients with VKH. It is recommended to avoid high-altitude areas (above 2500 m). As it may affect retinal health and cause complications such as vision problems, if it is necessary to go there, a protection plan should be formulated under the assessment of a doctor, and abnormal signs should be monitored. Protecting vision should be the top priority. The uniqueness of this VKH case offers new insights but also has limitations due to the small sample size and lack of a control group; future studies should increase sample size and perform multi-center epidemiological research on high-altitude exposure’s effects.Keywords: High-altitude conditions, Vogt-Koyanagi-Harada syndrome Background Vogt-Koyanagi-Harada (VKH) syndrome is a rare, systemic, immune-mediated disorder that primarily affects the eyes, skin, ears, and central nervous system. It is a chronic, progressive condition that most commonly affects young individuals of Asian descent but can also occur in other ethnic groups. The clinical course of VKH is divided into four phases: prodromal (mimics a viral infection), uveitic (bilateral diffuse uveitis with papillitis and exudative retinal detachment), convalescent (tissue depigmentation), and chronic recurrent (recurrent uveitis and ocular complications) [1]. Although the exact cause of VKH disease remains unknown, it is widely considered an autoimmune disorder in which the body’s immune system attacks pigment epithelial cells, particularly melanocytes. The fundamental pathological feature of VKH is the abnormal activation of the immune system, leading to immune-mediated damage of melanin-containing cells, especially the pigment epithelium of the eye, melanocytes in the skin and cochlea, and certain regions of the brain. The eye is the most frequently affected organ, with the choroid and retina commonly involved, often manifesting as retinal inflammation. High-altitude exposures, especially intense ultraviolet radiation and hypoxia, pose a significant and unavoidable threat to patients with VKH, High-altitude retinopathy (HAR) is a well-known predisposing, recurring, and exacerbating factor. HAR is a common eye disease during high-altitude mountaineering. Clinical symptoms vary, with common symptoms being retinal vasodilation, edema, and hemorrhage [2]. Therefore, it is strongly recommended that the vast majority of VKH patients, whether in the active or remission phase, avoid traveling to high-altitude regions, typically those above 2,500 m. This case not only highlights the potential impact of the high-altitude environment on the patient’s condition, but also demonstrates the rare manifestations of VKH, which holds significant clinical value and reference significance. Case presentation The patient is a 31-year-old female who presented with sudden blurred vision in both eyes lasting four days, accompanied by eye swelling, pain, conjunctival redness and swelling, frontal headache, and tinnitus in the right ear. She reported no nausea, vomiting, or history of hypertension, diabetes, or trauma. Ten days prior to presentation, she traveled to Lhasa, Tibet (average altitude 3,650 m) and stayed for six days. Following the onset of bilateral symptoms, she promptly left the high-altitude area. On physical examination, visual acuity was 0.12 in the right eye and 0.08 in the left eye (decimal Snellen notation is used in the VA). Intraocular pressure measured 11 mmHg in both eyes. Bilateral conjunctival injection, corneal flare (++), KP (+), no other anterior segment abnormalities were found. Fundus examination revealed clear optic disc margins with normal coloration, and exudative retinal detachment at the posterior pole. Skin examination revealed rash and hyperpigmentation on the face and upper arms. Neurological evaluation revealed mild meningeal irritation signs, suggesting possible central nervous system involvement. The patient was admitted with a diagnosis of VKH syndrome. Comprehensive laboratory tests, including hepatitis B and C, syphilis, HIV, complete blood count, coagulation profile, and biochemistry, along with chest X-ray and other relevant examinations, showed no significant abnormalities. Upon admission, bilateral anterior segment photography (Fig. 1), fundus photography (Fig. 2), macular optical coherence tomography (OCT) (Fig. 3), and fundus fluorescein angiography (Fig. 4) were performed, confirming the diagnosis of VKH. This patient is in the stage of uveitis (bilateral diffuse uveitis accompanied by retinitis and exudative retinal detachment). Treatment was initiated with a high-dose intravenous methylprednisolone sodium succinate injection at 1000 mg daily for three days, followed by a reduction to 500 mg daily for three days, with gradual tapering for long-term steroid control. After 10 days of treatment, anterior segment inflammation was controlled, as evidenced by anterior segment photography (Fig. 5). Follow-up bilateral macular OCT (Fig. 6) showed improvement in visual acuity to 0.4 in the right eye and 0.3 in the left eye. Intraocular pressures were 12 mmHg in the right eye and 14 mmHg in the left eye. Subsequent follow-up at one and two months demonstrated further improvement in visual acuity (right eye: 0.5; left eye: 0.4) and normalization of intraocular pressure. Fundus examination revealed significant and stable improvement. Front view of both eyes shows conjunctival hyperemia in both eyes, corneal flash (++), KP (+) Fundus photography of both eyes shows blurred optic disc margins and congestion in both eyes, multiple localized serous retinal detachments in the posterior pole and periphery of both eyes, and radial folds visible in the macular area Macular OCT: Both eyes show cyst-like areas of low reflectivity in the retinal layer and detachment of the neural epithelial layer Bifocal fundus angiography revealed: early-stage fluorescein leakage around the optic disc in both eyes, late-stage intense fluorescein signal around the optic disc, extensive fluorescein occlusion in the posterior pole of the retina during the early stage of angiography, fluorescein leakage during the angiographic process, and late-stage lake-like fluorescein accumulation. Fluorescein leakage at the terminal ends of peripheral retinal vessels. ICGA: Patchy fluorescence observed in the posterior pole of the retina Ten days after treatment, anterior segment photography showed that conjunctival hyperemia had subsided in both eyes, corneal flashes were negative, and KP was negative Ten days after treatment, follow-up OCT examination of both eyes showed that the cystic hyporeflective areas in the retinal layer had disappeared, and the detachment of the neural epithelial layer had improved significantly Discussion and conclusions VKH syndrome is a rare inflammatory disorder that affects multiple systems, including the eyes, ears, skin, and nervous system [3]. High-altitude illness (HAI) refers to a range of physiological and pathological responses triggered by hypoxia in environments above 2,500 m. Common symptoms include headache, nausea, insomnia, fatigue, and shortness of breath. The eye changes on the plateau can be classified as acute and chronic. Acute altitude-induced ocular changes typically refer to ocular disorders that occur in the body within a short period of time (from several hours to several days) under high-altitude conditions due to low pressure and oxygen deficiency. The main manifestations include retinal vessel dilation, optic disc edema, and retinal hemorrhage. These changes are commonly seen in individuals who rapidly ascend to high-altitude areas and have not adapted to the environment. Symptoms may appear within several days after exposure, and some patients may recover on their own. However, severe cases may affect vision. Chronic altitude-induced ocular changes refer to adaptive changes in the eyes that occur over a long period (more than several months) in a high-altitude environment. Such changes include choroidal thickening and increased dopamine levels in the retina. These changes are relatively subtle and are mostly associated with long-term living at high altitudes. They generally do not occur acutely, but may have long-term effects on the structure and function of the eyes. The effects of altitude sickness on VKH syndrome are particularly significant and dangerous. Potential effects of the high-altitude environment on VKH are as follows: 1) Strong ultraviolet radiation: VKH is considered to be an autoimmune attack on melanocytes, directly damaging melanocytes and releasing self-antigens, activating the immune response and promoting the release of inflammatory factors [4]. VKH affects melanin, but retinitis is not part of the disease. In high-altitude areas, the intensity of ultraviolet radiation increases (for every 1000 m increase in altitude, the ultraviolet radiation intensity increases by approximately 10%-12%), and the thin air offers almost no protection, putting VKH patients at a higher risk of ultraviolet radiation exposure, which may affect the onset, recurrence or progression of the disease. 2) Tissue hypoxia: It aggravates inflammation and autoimmune responses. It also activates inflammatory signaling pathways, such as HIF-1α, and promotes the production of pro-inflammatory cytokines and vasoactive substances, including TNF-α, IL-1, IL-6, and VEGF. These factors are crucial for the inflammatory response in VKH. One of the main manifestations of VKH involves ocular signs [5], optical coherence tomography (OCT) allows earlier diagnosis of VKH disease by revealing heterogeneous exudative detachments of the retina in the acute stage and choroidal thickening, and by demonstrating choroidal thinning in the chronic stage [6]. Hypoxic conditions at high altitudes can reduce ocular blood flow and oxygen supply, aggravate symptoms, and increase oxidative stress. These effects damage retinal cells, may impair immune cell function, and disrupt immune tolerance. The core pathological feature of VKH is choroidal thickening with inflammatory cell infiltration [7]. Hypoxia can increase choroidal vascular permeability, which may cause retinal detachment and promote new blood vessel formation [8]. 3) Compensatory blood pressure elevation, vascular dysregulation, and vascular endothelial damage: Hypoxia-induced responses at High-altitude significantly increase systemic vascular permeability [9]. Directly disrupting the already compromised blood-ocular and blood-brain barriers during VKH inflammation can lead to aqueous flare and increased cellularity, increased fibrinous exudates, enlarged or poorly absorbed serous retinal detachment, and worsening macular edema (severely impairing vision). Neurologically, this can induce or exacerbate VKH-related meningeal irritation symptoms, such as headaches, tinnitus, hearing loss, and neck stiffness. 4) The combined effects of acute high-altitude hypoxic stress and ultraviolet radiation can activate the immune system, shifting the overall immune status toward pro-inflammatory levels. This creates fertile ground for an autoimmune attack against melanocytes, exacerbating inflammatory responses in the eye and other organs. Some VKH patients may experience relatively stable disease at High-altitude, while others may experience significant exacerbation. Factors influencing this include the patient’s immune status, disease severity, and whether they have received effective treatment. Inflammation plays a crucial role in the physiological response to hypoxia. High-altitude hypoxia exposure causes alterations in the inflammatory cytokine levels [10]. Overall, high-altitude environments can influence the pathogenesis of autoimmune diseases by disrupting immune homeostasis. Therefore, more meticulous observation and management of VKH syndrome patients in plateau environments are needed to avoid misdiagnosis or delayed treatment. High-altitude exposures, particularly the intense ultraviolet radiation and hypoxia they involve, have the potential to contribute to the development of VKH. These factors serve as clear triggers, contribute to disease recurrence, and exacerbate symptoms. For the vast majority of VKH patients, whether in the active or remission phase, it is recommended to avoid traveling to high-altitude regions, typically those above 2,500 m. If one is in an environment at a high altitude, it may have an adverse effect on the health of the retina and lead to the occurrence of various eye diseases [11]. If travel to high-altitude areas is unavoidable due to unforeseen circumstances, it should only occur after a thorough risk assessment by a qualified physician, along with the implementation of a comprehensive protective and emergency plan and continuous monitoring. Due to the unique circumstances of VKH patients, caution is required. The fundamental principle is to evacuate immediately and seek medical attention at the first sign of any abnormalities. However, such precautions apply to all patients with ocular pathology, and perhaps even more so to individuals with systemic hypertension—given its high prevalence—and with some degree of hypertensive retinopathy. Protecting vision must remain the top priority, unnecessary risks should be avoided. Although the uniqueness of this case provides a new perspective for understanding the pathogenesis of VKH, this case and its analysis also have limitations, mainly due to the small sample size and the lack of a control group. Future research should expand the sample size and conduct multi-center epidemiological studies to verify the specific impact of high-altitude exposure on VKH syndrome. Acknowledgements The work described in this article was carried out with the financial support of Gansu Provincial Hospital.The sponsors had no input in the case, and did not influence manuscript preparation. Abbreviations Vogt-Koyanagi-Harada Optical Coherence Tomography Visual acuity High-altitude illness High-altitude retinopathy Author contributions Xiangli Wang developed the conceptual framework for the case. Qihang Lei administrated the case, edited the data, prepared the initial draft, reviewed the literature, and revised the manuscript. Qin Liu confirmed the diagnosis and analyzed the whole process. Funding This work was supported by Gansu Natural Science Foundation (No. 22JR5RA675) and the Internal Research Fund project of Gansu Provincial Hospital (No. 21GSSYC-9). Data availability Non applicable. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Written informed consent was obtained from the patient for publication and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Qihang Lei and Xiangli Wang contributed equally to this work. References Associated Data Data Availability Statement Non applicable.